To test this hypothesis, we conducted a meta-analysis on genetic alterations in LEP and ADIPOQ genes as well as their receptor-encoded genes by pooling published summary data, aiming to evaluate their association with risk for breast cancer, as well as circulating leptin and adiponectin levels. Here, LEP is linked to breast cancer.